Persevering with a optimistic latest development, Third Hamonic Bio is doing many of the heavy lifting for us, THRD disclosed their estimate for money on 6/30:
Assuming no use of their ATM between 11/1 and at this time, I get the next again of the envelope liquidation worth (once more, this doubtless will not liquidate):
The shareholder base appears fairly good right here, Atlas Ventures and OrbiMed Advisors personal collectively about 25% of the corporate, different acquainted names are current in EcoR1 Capital, BVF Companions and RA Capital. A reverse merger is probably going right here, presumably with a CVR hooked up to THB335. I added a small place to the rising damaged biotech basket (want some extra momentum in deal bulletins to filter out room).
Disclosure: I personal shares of THRD